EGS Healthcare Capital Partners is a healthcare private equity firm that invests in late stage private and emerging public healthcare
EGS Healthcare Capital Partners is a healthcare private equity firm that invests in late stage private and emerging public healthcare companies with promising commercial products that are either on the market or in late stages of development. The Principals of the firm presently manage two funds with combined committed capital of more than $135 million.
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
---|---|---|---|---|
Mar 21, 2006
![]() |
Series C | $26M | Health Care | — |
Oct 10, 2005
![]() |
Series Unknown | $36M | Biotechnology | — |
Aug 23, 2005
![]() |
Series A | $50M | Biotechnology | — |
May 23, 2005
![]() |
Series Unknown | $15M | Health Care | — |
Feb 18, 2005
![]() |
Series B | $18M | Health Care | — |
EGS Healthcare Capital Partners has had 7 exits. EGS Healthcare Capital Partners most notable exits include EKOS Corporation , Alveolus
Date | Company Name | Exit Type | Industry | |
---|---|---|---|---|
May 23, 2013 | EKOS Corporation | M&A | Health Care | Detail |
Feb 19, 2009 | Alveolus | M&A | Medical | Detail |
May 31, 2007 | Jazz Pharmaceuticals | IPO | Biotechnology | Detail |
Feb 9, 2007 | Endius | M&A | Health Care | Detail |
Dec 14, 2006 | Cerexa Inc. | M&A | Biotechnology | Detail |